Versiti Leukopaks are enriched, fresh leukapheresis products composed of high concentrations of monocytes and lymphocytes, but may also contain lower concentrations of platelets, plasma and red cells. Specific product characterization available upon request to meet unique study needs. Our Leukopaks are available for Research Use Only and Clinical Grade (FDA 21 CFR 1271-compliant) applications.
Expected TNC Count: ~10-15B TNC (Product TNC yield may vary, depending on individual contributors.)
Standard Infectious Disease Screening: CMV Antibody, Hepatitus B Surface Antigen, Hepatitus C Core Antibody, Hepatitis C Virus Antibody, HIV Antibody, Human T-Lymphotropic Virus, Trypanasoma cruzi Antibody (Chagas), West Nile Virus (WNV).
Quality Assurance: PBMC products are collected in Versiti’s FDA-registered collection centers following SOPs and formal quality systems that result in reduced variability and risk. PBMCs are collected from a single IRB-consented contributor by leukapheresis using the Spectra Optia Apheresis System continuous mononuclear cell (CMNC) collection procedure. Each product receives a Certificate of Analysis (COA).